Skip to main content

Peer Review reports

From: CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway

Original Submission
9 Nov 2023 Submitted Original manuscript
2 Dec 2023 Reviewed Reviewer Report - Ke Xu
29 Jan 2024 Reviewed Reviewer Report
28 Feb 2024 Author responded Author comments - Jun Ou-Yang
Resubmission - Version 2
28 Feb 2024 Submitted Manuscript version 2
1 Apr 2024 Reviewed Reviewer Report
7 Apr 2024 Reviewed Reviewer Report
11 Apr 2024 Author responded Author comments - Jun Ou-Yang
Resubmission - Version 3
11 Apr 2024 Submitted Manuscript version 3
12 Apr 2024 Reviewed Reviewer Report
30 Apr 2024 Author responded Author comments - Jun Ou-Yang
Resubmission - Version 4
30 Apr 2024 Submitted Manuscript version 4
7 May 2024 Reviewed Reviewer Report
16 May 2024 Author responded Author comments - Jun Ou-Yang
Resubmission - Version 5
16 May 2024 Submitted Manuscript version 5
Publishing
20 May 2024 Editorially accepted
27 May 2024 Article published 10.1186/s12885-024-12402-7

You can find further information about peer review here.

Back to article page